Antibacterial Mechanism of Chitosan-Gentamicin and Its Effect on the Intestinal Flora of Litopenaeus vannamei Infected with Vibrio parahaemolyticus

Mar Drugs. 2022 Nov 9;20(11):702. doi: 10.3390/md20110702.

Abstract

To explore the application of chitosan-gentamicin conjugate (CS-GT) in inhibiting Vibrio parahaemolyticus (V. parahaemolyticus), which is an important pathogen in aquatic animals worldwide, the antimicrobial activity of CS-GT and the effects of a CS-GT dose on the intestine histopathology and intestinal flora of V. parahaemolyticus-infected shrimps were explored. The results showed that CS-GT possessed broad-spectrum antibacterial activity, with minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and half inhibitory concentration (IC50) of 20.00 ± 0.01, 75.00 ± 0.02 and 18.72 ± 3.17 μg/mL for V. parahaemolyticus, respectively. Further scanning electron microscope and cell membrane damage analyses displayed that the electrostatic interaction of CS-GT with cell membrane strengthened after CS grafted GT, resulting in leakage of nucleic acid and electrolytes of V. parahaemolyticus. On the other hand, histopathology investigation indicated that high (100 mg/kg) and medium (50 mg/kg) doses of CS-GT could alleviate the injury of a shrimp's intestine caused by V. parahaemolyticus. Further 16S rRNA gene sequencing analysis found high and medium dose of CS-GT could effectively inhabit V. parahaemolyticus invasion and reduce intestinal dysfunction. In conclusion, CS-GT possesses good antibacterial activity and could protect shrimps from pathogenic bacteria infection.

Keywords: Vibrio parahaemolyticus; antimicrobial mechanism; chitosan; intestine microbe.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology
  • Chitosan* / metabolism
  • Chitosan* / pharmacology
  • Gastrointestinal Microbiome*
  • Gentamicins / pharmacology
  • Penaeidae* / genetics
  • RNA, Ribosomal, 16S / metabolism
  • Vibrio parahaemolyticus*

Substances

  • Chitosan
  • Gentamicins
  • RNA, Ribosomal, 16S
  • Anti-Bacterial Agents

Grants and funding

This work was supported by Guangdong Provincial Natural Science Foundation of China (2020A1515011011) and Mangrove Institute of LingNan Normal University (PYXM10).